Bicyclic heteroaryl inhibitors of PDE4

Details Bicyclic heteroaryl inhibitors of PDE4 Bicyclic heteroaryl inhibitors of PDE4

2007-07-06

2011-12-20

Fetterolf, Brandon (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S157000

Reexamination Certificate

active

08080563

ABSTRACT:
The present invention relates to compounds and methods which may be useful as inhibitors of phosphodiesterase 4 (PD E4) for the treatment or prevention of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators.

REFERENCES:
patent: 5412104 (1995-05-01), Afonso
patent: 2003/0028018 (2003-02-01), Renhowe
patent: 2006/0223783 (2006-10-01), Xu
patent: 639529 (1991-05-01), None
patent: 2002371078 (2002-12-01), None
patent: 92/17452 (1992-10-01), None
patent: 9932449 (1999-07-01), None
patent: 02/22598 (2002-03-01), None
patent: 03/066630 (2003-08-01), None
patent: 2004/018419 (2004-03-01), None
patent: 2005/082340 (2005-09-01), None
patent: 2006/032631 (2006-03-01), None
patent: 2007/036743 (2007-04-01), None
Stella et al. (Prodrugs: Challenges and Rewards, Part 1, 2007).
O'Donnell, F. et. al.; A study of the analytical behaviour of selected synthetic and naturally occurring quinolines using electrospray ionisation ion trap mass spectrometry, liquid chromatography and gas chromatography and the construction of an appropriate database for quinoline characterisation; Analytica chimica acta, 2006, vol. 572, No. 1, pp. 63-76.
Nadaraj, Vetrivel et. al.; Microwave-assisted synthesis of quinoline alkaloids: 4-Methoxy-1-methyl-2-quinolinone and its analogs; ARKIVOC, (10), 82-89, 2006.
Platonov, V.V. et. al.; Genetic Relationship of Organic Bases of the Quinoline and Isoquinoline Series from Lignite Semicoking Tars with the Initial Biological Material; Russian Journal of Applied Chemistry, 2002, 75(4), 649-55.
Ishii, Hisashi; Abstract “Alkaloids of rutaceous plants. XIV. Synthesis of some hydrogenated derivatives of skimmianine”; Chemical Abstracts Service: XP002477164 Yakugaku Zasshi, 1961, 81, 248-53.
Ohta, Tatsuo et. al.; Abstract “Furoquinolines. VI. Establishment of the linear tri-cyclic structures for dictamine and skimmianine”; Chemical Abstracts Service: XP00247715 Ann. Rept. Tokyo Coll. Pharm., 1955, 5, 336-8.
Rasulova, Kh. A. et. al.; Abstract “Alkaloids of Haplophyllum perforatum”; Chemical Abstracts Service: XP002477166 Khimiya Prirodnykh Soedinenii, 1992, 2, 249-51.
Bessonova, IA et. al.; Abstract “7-Isopentenylhydroxy-gamma-fagarine from Haplophyllum perforatum”; Chemical Abstracts Service: XP002477167, Khimiya Prirodnykh Soedinenii, 1974, 5, 677-8.
Dobronravova, E.K. et. al.; Abstract “Reduction mechanism of haplophyllum alkaloids on the mercury dropping electrode”; Chemical Abstracts Service: XP002477168, Khimiya Prirodnykh Soedinenii, 1967, 3(4), 253-7.
Ratusky, Josef et. al.; Abstract “Quinolizine alkaloids. III. Synthesis of three isomeric 3-(alpha-piperidyl)quinolizidines”; Chemical Abstracts Service: XP002477169, Collection of Czechoslovak Chemical Communications, 1954, 19, 107-16.
The prosecution history of U.S. Appl. No. 11/774,053 (a co-pending application).
Govek, Steven P., WO2008006050 IPRP, Jan. 22, 2009.
Response to Office Action in CN200780033048.0, Jan. 17, 2011.
Dec. 8, 2010. First Office Action in CN200780033048.0.
The prosecution history of U.S. Appl. No. 11/774,053 (a co-pending application) Filed Jul. 6, 2007.

Affiliated with

Also associated with

Rating

Bicyclic heteroaryl inhibitors of PDE4 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic heteroaryl inhibitors of PDE4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heteroaryl inhibitors of PDE4 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4252784